Navigation Links
New Evidence Found for CRP as an Independent Marker for Heart Disease, Stroke
Date:11/17/2008

A new study published in the New England Journal of Medicine lends further importance to the screening of C-reactive protein (CRP) in the detection of heart disease and stroke risk. Life Line Screening provides CRP screening along with glucose and cholesterol screenings.

Cleveland, OH (PRWeb) November 17, 2008 -- New clinical evidence indicates that a measurement called high-sensitivity C-reactive protein (CRP) is an independent marker that can pinpoint those at risk for stroke or heart attack even when cholesterol measurements are normal. Life Line Screening, the nation's leading provider of community-based preventive health screenings, includes testing for this risk indicator among its services.

Healthcare professionals traditionally view high levels of low-density lipoprotein (LDL) or "bad cholesterol" as the primary blood measurement for stroke and heart disease risk.

"Attention to CRP should not be avoided, as the new study in the NEJM indicates," states Andrew Manganaro, MD, FACS, FACC, Chief Medical Officer of Life Line Screening. "The results of this study shed light on the fact that half of all cardiovascular events occur in people without high cholesterol. The need to screen for other potential risk indicators is clear, and the medical community is beginning to explore this fact. We are proud to be able to offer the CRP screening along with our other testing services."

CRP is a marker of inflammation in the body. Previous studies suggested that its significance for cardiovascular disease was limited to cases in which it was coupled with a high LDL measurement. The new study, published in the New England Journal of Medicine, now reveals that CRP is an effective independent predictor for increased risk of heart disease, even among individuals whose LDL cholesterol counts were found to be at normal levels. These new findings are prompting the medical community to take a new look at how they identify at-risk individuals.

About Life Line Screening
Life Line Screening, the nation's leading provider of preventive health screenings, offers a simple finger-stick blood test that checks for elevated CRP levels, in most states. Results are ready minutes after the screening and can provide a better understanding of a person's risk for heart disease and stroke. Finger-stick blood tests for diabetes and cholesterol levels are also available.

All three screenings--CRP, glucose and cholesterol--are available for $70.

For more information regarding the screenings or to schedule an appointment, call 1-800-697-9721 or visit www.lifelinescreening.com. Pre-registration is required.

###

Read the full story at http://www.prweb.com/releases/CRP-study/CRP-screening/prweb1618124.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Jefferson researchers uncover new evidence of prolactins possible role in breast cancer
2. No strong evidence linking amateur boxing with long-term brain injury
3. AHRQ Announces Next Phase of Its Evidence-Based Practice Center Program
4. Vanderbilt Medical Center chosen as Evidence-based Practice Center
5. Little Evidence Silicone Breast Implants Harm Health
6. Consumers Should Demand Evidence, Not Guesswork, On Meat-Cancer Links
7. U of M study: Medicare lacks tools, incentives to enforce evidence-based coverage policies
8. New Study Provides Scientific Evidence That DermaLastyl Face Cream Reduces Wrinkles
9. Scientific evidence of the significant anti-cancer effect of milk thistle
10. Defining the Value of Medicine in an Evidence-Based Healthcare Marketplace
11. UC Davis researchers find evidence of mature heart cell potential in embryonic stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Evidence Found for CRP as an Independent Marker for Heart Disease, Stroke 
(Date:1/20/2017)... ... ... “The Land of More and More”: a brilliant story for children ... the simple and achievable answer. “The Land of More and More” is the creation ... in Angola, Indiana where he works with the children’s ministry department. , Michael ...
(Date:1/19/2017)... Los Angeles (PRWEB) , ... January 19, 2017 , ... ... Care Act will be repealed by Congressional political games that circumvent health needs of ... First Stand Rally” capture the human anxieties and needs government public servants were suppose ...
(Date:1/19/2017)... Ca (PRWEB) , ... January 19, 2017 , ... ... events for tech innovators, engineers, and scientists from around the world, announces the ... offers users a quick and easy portal to research breakthroughs and trending news, ...
(Date:1/19/2017)... ... January 19, 2017 , ... WholeHealth is announcing their participation ... Paziotopoulos, Andrew Petersen and Trish Henrie-Barrus will be present Saturday and Sunday in ... program. , “We know it’s easy to get carried away when you’re ...
(Date:1/19/2017)... ... January 19, 2017 , ... Bio-Optronics ... provides a modern CTMS workflow designed to seamlessly integrate and streamline the way ... to a single page, maximizing usability and improving efficiency significantly for users – ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 The U.S. Food and Drug Administration ... Constipation (CIC) in adult patients. "No one ... said Julie Beitz , M.D., director of the Office ... Evaluation and Research. "With the availability of new therapies, patients ... their condition." ...
(Date:1/19/2017)...  Stealth BioTherapeutics Inc. ( Stealth ), a clinical-stage ... announced new additions to its senior leadership team: ... and Daniel Geffken as interim Chief Financial ... , Pharm.D. has been promoted to Chief Clinical Development ... Doug and Daniel to our management team, as both ...
(Date:1/19/2017)... 19, 2017 James ... & Haematology, 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... Published recently in a supplement to European ... touchONCOLOGY, an article by James Gilbart ...
Breaking Medicine Technology: